Review article · 2026 · Open access

Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review

Deepak Mewada, Muskan Tomar, Manoj Goyal

Premier journal of science. · Published 11 April 2026 · DOI 10.70389/pjs.100272

Free PDFView at the publisherCite this paper

In brief

“Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review” is a 2026 review article by Deepak Mewada and 2 co-authors, published in Premier journal of science.. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Premier journal of science..

Citations
0
References
40
Authors
3

Abstract

Alzheimer's disease, a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and neuronal death, has multiple inter-connected mechanisms that contribute to its pathogenesis (the largest factor being amyloid beta accumulation; however, other factors such as hyperphosphorylated tau protein accumulation, oxidative stress, mitochondrial dysfunction, and inflammatory response are also involved). Currently available drug treatments, such as cholinesterase inhibitors and NMDA receptor antagonists, relieve symptoms but do not significantly influence the progression of the disease itself. Increased knowledge regarding the relevant molecular pathways involved in the pathogenesis of the disease has led to the recent development of additional potential pharmaceutical targets that may be used to create more effective therapies aimed at delaying or preventing Alzheimer's Disease. New strategies are emerging for the development of treatment approaches that include anti-amyloid and anti-tau treatment approaches, inhibition of kinases, neuroprotective agents, and modulation of inflammatory signaling pathways. Overall, this review covers the major pharmacological targets that have been identified in Alzheimer's disease as well as the current treatments available for the disease, discusses the limitations of those treatments, and presents recent advances in the development of therapeutics to modify the pathological processes associated with Alzheimer's disease. Understanding these pharmacological strategies will ultimately improve the ability to develop therapeutics for delaying or halting the progression of Alzheimer's disease.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mewada, D., Tomar, M., & Goyal, M. (2026). Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review. Premier journal of science.. https://doi.org/10.70389/pjs.100272

MLA 9

Mewada, Deepak, et al. “Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review.” Premier journal of science., 2026. https://doi.org/10.70389/pjs.100272.

Chicago

Mewada, Deepak, Muskan Tomar, and Manoj Goyal. 2026. “Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review.” Premier journal of science.. https://doi.org/10.70389/pjs.100272.

Harvard

Mewada, D., Tomar, M. and Goyal, M. (2026) ‘Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review’, Premier journal of science.. doi:10.70389/pjs.100272.

IEEE

D. Mewada, M. Tomar, and M. Goyal, “Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review,” Premier journal of science., 2026, doi: 10.70389/pjs.100272.

BibTeX

@article{mewada2026pharmacological,
  title     = {{Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review}},
  author    = {Mewada, Deepak and Tomar, Muskan and Goyal, Manoj},
  journal   = {Premier journal of science.},
  year      = {2026},
  doi       = {10.70389/pjs.100272},
  url       = {https://doi.org/10.70389/pjs.100272}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • therapeutic target
  • amyloid-beta
  • tau hyperphosphorylation
  • oxidative stress
  • mitochondrial dysfunction
  • neuroinflammation
  • cholinesterase inhibitors

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Mewada, D., Tomar, M., & Goyal, M. (2026). Pharmacological Targets and Therapeutic Strategies in Alzheimer's Disease: Mechanistic Insights and Emerging Drug Approaches—A Narrative Review. Premier journal of science.. https://doi.org/10.70389/pjs.100272

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Premier journal of science..

Who wrote this paper?

Deepak Mewada, Muskan Tomar, Manoj Goyal.

What is the DOI of this paper?

10.70389/pjs.100272. The permanent link is https://doi.org/10.70389/pjs.100272.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.